We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
–
AUM
$244M
AUM Growth
+$165M
Cap. Flow
+$161M
Cap. Flow %
65.83%
Top 10 Hldgs %
66.41%
Holding
119
New
13
Increased
60
Reduced
45
Closed
1

Top Buys

Rank Stock Value
1
HKND
Humankind US Stock ETF
HKND
+$73.1M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$18M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$13.9M
4
AAPL icon
Apple
AAPL
+$13.3M
5
MSFT icon
Microsoft
MSFT
+$11.1M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$303K
2
THS
Treehouse Foods
THS
+$221K
3
MCK icon
McKesson
MCK
+$206K
4
TMO icon
Thermo Fisher Scientific
TMO
+$200K
5
BMY icon
Bristol-Myers Squibb
BMY
+$172K

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Healthcare 12.65%
3 Consumer Staples 5.56%
4 Communication Services 4.92%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LLY icon
26
Eli Lilly
LLY
$1.06T
$1.44M 0.59%
5,027
+596
+13% +$153K
MCK icon
27
McKesson
MCK
$101B
$1.21M 0.5%
3,964
-756
-16% -$206K
XYL icon
28
Xylem
XYL
$28.1B
$1.18M 0.48%
13,807
+4,523
+49% +$433K
AMGN icon
29
Amgen
AMGN
$222B
$1.16M 0.48%
4,806
-186
-4% -$42.7K
CF icon
30
CF Industries
CF
$17.3B
$1.13M 0.46%
11,002
-885
-7% -$71.4K
ECL icon
31
Ecolab
ECL
$79.9B
$1.11M 0.45%
6,295
+1,705
+37% +$320K
UNH icon
32
UnitedHealth
UNH
$370B
$1.05M 0.43%
2,061
-50
-2% -$24.1K
IQV icon
33
IQVIA
IQV
$39.3B
$1.04M 0.43%
4,507
+839
+23% +$199K
FMC icon
34
FMC
FMC
$1.33B
$1.03M 0.42%
7,866
-653
-8% -$76.8K
MOS icon
35
The Mosaic Company
MOS
$7.33B
$1.02M 0.42%
15,362
-3,081
-17% -$154K
LH icon
36
Labcorp
LH
$25.9B
$1.02M 0.42%
4,505
+448
+11% +$105K
CMCSA icon
37
Comcast
CMCSA
$90B
$922K 0.38%
19,688
+2,649
+16% +$128K
CAH icon
38
Cardinal Health
CAH
$55.4B
$893K 0.37%
15,750
-1,156
-7% -$61.9K
T icon
39
AT&T
T
$163B
$819K 0.34%
45,863
+2,342
+5% +$43.3K
GILD icon
40
Gilead Sciences
GILD
$165B
$814K 0.33%
13,695
+1,928
+16% +$123K
JPM icon
41
JPMorgan Chase
JPM
$950B
$776K 0.32%
5,692
+504
+10% +$74.4K
BAC icon
42
Bank of America
BAC
$442B
$733K 0.3%
17,780
+370
+2% +$16.7K
THC icon
43
Tenet Healthcare
THC
$21.1B
$720K 0.29%
8,379
-283
-3% -$23.2K
TMO icon
44
Thermo Fisher Scientific
TMO
$220B
$688K 0.28%
1,165
-348
-23% -$200K
DGX icon
45
Quest Diagnostics
DGX
$26.3B
$686K 0.28%
5,009
+792
+19% +$110K
HPQ icon
46
HP
HPQ
$27.5B
$686K 0.28%
18,909
-2,203
-10% -$81.4K
AGCO icon
47
AGCO
AGCO
$7.2B
$678K 0.28%
4,641
-144
-3% -$18.2K
CL icon
48
Colgate-Palmolive
CL
$74.4B
$636K 0.26%
8,387
+146
+2% +$11.6K
MDLZ icon
49
Mondelez International
MDLZ
$79.9B
$630K 0.26%
10,032
-369
-4% -$24K
BDX icon
50
Becton Dickinson
BDX
$48.2B
$624K 0.26%
2,406
-50
-2% -$12.9K
1
2
3 4 5

Similar funds

MWM
Momentous Wealth Management Vancouver, Washington $175M AUM 14.91% 1-Year Est. Return
BCVI
Bain Capital Venture Investors Boston, Massachusetts $175M AUM 21.91% 1-Year Est. Return
CC
Converium Capital Montreal $175M AUM
BW
Basepoint Wealth Cedar Rapids, Iowa $175M AUM 43.04% 1-Year Est. Return
DWA
Delos Wealth Advisors Dallas, Texas $175M AUM 19.35% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Humankind Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Humankind Investments held 119 positions worth $244M, up 208% from $79.4M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Humankind Investments deployed $161M of net new capital in Q1 2022, opening 13 new positions and adding to 60 existing holdings. Its largest new stake was Humankind US Stock ETF: 2,539,178 shares worth $74.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was AbbVie, an estimated $303K trimmed.

  • Humankind Investments's largest Q1 2022 buy was Humankind US Stock ETF: 2,539,178 shares worth $74.7M.
  • Humankind Investments added most to Alphabet (Google) Class A in Q1 2022, an estimated $685K increase.
  • Humankind Investments's biggest Q1 2022 reduction was AbbVie, cutting an estimated $303K.
  • Humankind Investments fully exited Treehouse Foods in Q1 2022, selling an estimated $221K.
  • Humankind Investments's ten largest holdings make up 66% of its $244M portfolio in Q1 2022.
  • Humankind Investments opened 13 new positions and closed 1 in Q1 2022.
  • Humankind Investments's portfolio value rose 208% quarter-over-quarter to $244M.

Based on Humankind Investments's 13F filing for Q1 2022, filed 9 May 2022.